A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
Summary
- Eligibility
- for people ages 6-17 (full criteria)
- Location
- at Orange, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Amgen
- Links
- AmgenTrials clinical trials website
- ID
- NCT06088199
- Phase
- Phase 3 Psoriasis Research Study
- Study Type
- Interventional
- Participants
- Expecting 50 study participants
- Last Updated